|
| [September 19, 2007] |
 |
Guardian Details Strategic Plan to Commercialize Groundbreaking PinPoint Product in New Investor Video
HERNDON, Va. --(Business Wire)-- Guardian Technologies International (OTCBB:GDTI), innovators of groundbreaking medical imaging and threat detection technology with critical and immediate applications for the healthcare and homeland security markets, today announced the availability of a new online investor video highlighting the Company's groundbreaking threat-detection PinPoint product targeting the multibillion dollar global Homeland Security market.
"The main culprit behind long and tedious lines at airport security checkpoints is the inability of current technology to quickly and definitively identify suspect materials from harmless products such as toothpaste and lotions or gels," said Steve Lancaster, Vice President of Guardian Technologies in the new video. "PinPoint(TM) delineates between these substances and delivers full image analysis of a threat in real time. And the technology can be run on a laptop with the existing infrastructure."
PinPoint enhances current-generation security x-ray scanners with the ability to autonomously determine the presence of contraband items of interest--such as explosives, weapons, currency or illegal drugs--rather than relying on human operator vigilance and interpretation.
"While augmenting airport scanners represents a major revenue opportunity for Guardian, the basis of our patent protected technology can be easily adapted to cargo and container scanning and for the detection of illicit drugs, as well as medical imaging applications," said Mr. Lancaster. "Whether hidden or in plain sight, the operator would receive an incontrovertible alert, thereby improving convenience, productivity and quickly defusing real or potential threats."
PinPoint is based on the same core technology, Signature Mapping, which has been targeted at the massive healthcare sector. Signature Mapping is an advanced analysis and visualization technology that can be seamlessly installed to read images from any medical imaging device (including MRIs, CT-scans and x-rays) to detect disease states in the brain, lungs, heart, prostate and can even visualize breast cancer in difficult to distinguish dense breast tissue.
Protected by a robust patent portfolio, Guardian's technology can be seamlessly added to existing imaging devices and significantly enhances images to quickly and accurately identify a myriad of threats, be they medical or terrorist related. Guardian is committed to aggressively marketing its first to market digital imaging solutions to both the healthcare and Homeland security sectors.
To view the entire video presentation, please visit: http://www.trilogy-capital.com/tcp/guardian.
About Guardian Technologies International
The impact of Guardian's industry-first computer aided detection technologies are immediate and profound for helping to eliminate human error in both the Homeland Security and the Medical Industry sectors. The Company's software solutions can be seamlessly installed to complement existing imaging devices, such as baggage scanners and medical MRI, to scan the contents of any image and immediately identify items of interest not easily discernable by the human eye.
-- Airport Security: Guardian's technology complements and enhances current-generation baggage x-ray scanners with the ability to automatically and effectively detect, locate, and identify explosives and other types of threats.
-- Disease Identification: Existing medical imaging devices used in Computer Aided Detection (CAD) are further improved with Guardian's auto-diagnostic ability to detect anomalous tissue (e.g., tumors) and other potential disease states or conditions.
-- Technology-Independence: Because Guardian's technologies utilize and process the actual image output generated by the original imaging systems, virtually any existing or future imaging device can be upgraded with Guardian's products, delivering an instant, multibillion-dollar potential customer base with no competition.
Guardian's technology and product development partnerships include a Cooperative Research and Development Agreement (CRDA) with the U.S. Department of Homeland Security - Science and Technology Directorate. The Company's platform and product suite is protected by a robust patent portfolio. They are also ramping up new technologies and plan to acquire complementary technologies to accelerate the Company's high-growth business model.
For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/guardian.
To view current stock quotes and news, visit http://www.trilogy-capital.com/tcp/guardian/quote.html.
To view an investor fact sheet about the company, visit http://www.trilogy-capital.com/tcp/guardian/factsheet.html.
Forward-Looking Statements
This news release contains forward-looking statements that involve risks and uncertainties. Forward-looking statements in this document and those made from time to time by Guardian through its senior management are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company's current views with respect to the future events or financial performance discussed in this release, based on management's beliefs and assumptions and information currently available. When used, the words "believe," "anticipate," "estimate," "project," "should," "expect," "plan," "assume" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Forward-looking statements concerning future plans or results are necessarily only estimates and actual results could differ materially from expectations. Certain factors that could cause or contribute to such differences include, among other things, in particular, the size and timing of contract awards, performance on contracts, performance of acquired companies, availability and cost of key components, unanticipated results from audits of the financial results of the Company and acquired companies, changing interpretations of generally accepted accounting principles, outcomes of government reviews, developments with respect to litigation to which we are a party, potential fluctuations in quarterly results, dependence on large contracts and a limited number of customers, lengthy sales and implementation cycles, market acceptance of new or enhanced products and services, proprietary technology and changing competitive conditions, system performance, management of growth, dependence on key personnel, ability to obtain project financing, general economic and political conditions and other factors affecting spending by customers, the unpredictable nature of working with government agencies and other risks, uncertainties and factors including those described from time to time in Guardian's filings with the Securities and Exchange Commission, including without limitation, Guardian's Form 10-K for the year ended December 31, 2006, and its quarterly reports on Form 10-Q. Guardian expressly disclaims any obligation to update any forward-looking statements.
[ Back Hosted VoIP Global Community's Homepage ]
|
SUBSCRIPTIONS
Activate Email 
TMCnet LOGIN
